Loading…
Establishment and clinical application evaluations of a deep mining strategy of plasma proteomics based on nanomaterial protein coronas
Research on plasma proteomics has received extensive attention, because human plasma is an important sample for disease biomarker research due to its easy clinical accessibility and richness in biological information. Plasma samples contain a large number of leaked proteins from different tissues in...
Saved in:
Published in: | Analytica chimica acta 2023-09, Vol.1275, p.341569-341569, Article 341569 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c348t-8f123553aa7fb0fc37e7d1c03f08627ddec2eb304d145454bc96f33e142766283 |
container_end_page | 341569 |
container_issue | |
container_start_page | 341569 |
container_title | Analytica chimica acta |
container_volume | 1275 |
creator | Wang, Jianan Xie, Wei Sun, Longqin Li, Jingli Wu, Songfeng Li, Ruibing Zhao, Yan |
description | Research on plasma proteomics has received extensive attention, because human plasma is an important sample for disease biomarker research due to its easy clinical accessibility and richness in biological information. Plasma samples contain a large number of leaked proteins from different tissues in the body, immune proteins and communication signal proteins. However, MS signal suppression from high-abundance proteins results in a large number of proteins that are present in low abundance in plasma not being detected by the LC-MS method. This situation makes it more difficult to study neurological diseases, where tissue sampling is difficult and body fluid samples such as plasma or cerebrospinal fluid are both affected by signal suppression. A large number of methods have been developed to deeply mine plasma proteomics information; however, their application limitations remain to some extent. Traditional immuno- or affinity-based depletion, fractionation and subproteome enrichment methods cannot meet the challenges of large clinical cohort applications due to limited time efficiency.
In this study, a deep mining strategy of plasma proteomics was established by combing the protein corona formed by deep mining beads (DMB beads, hereafter referred to as magnetic covalent organic frameworks Fe3O4@TpPa-1), DIA-MS detection and the DIA-NN library searching method. By optimizing the enrichment step, mass spectrometry acquisition and data processing, the evaluation results of the deep mining strategy showed the following: depth, the strategy identified and quantified results of 2000+ proteins per plasma sample; stability, more than 87% of the enriched low-abundance proteins had CV < 20%; accuracy, good agreement between measured and theoretical values (1.81/2, 8.68/10, 38.36/50) for the gradient addition of E. coli proteins to a plasma sample; time efficiency, the processing time was reduced from >12h in the traditional method to |
doi_str_mv | 10.1016/j.aca.2023.341569 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2844680513</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0003267023007900</els_id><sourcerecordid>2844680513</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-8f123553aa7fb0fc37e7d1c03f08627ddec2eb304d145454bc96f33e142766283</originalsourceid><addsrcrecordid>eNp9kMtOHDEQRa0oKAwkH8AGeZlNT_zqB2KFEC8JKZuwtqrtavDIbTe2B4kvyG_jYSDLyAuXVaeuVYeQE87WnPHu12YNBtaCCbmWirfd2Rey4kMvGyWF-kpWjDHZiK5nh-Qo5019Cs7UN3Io-1Yo1YkV-XuVC4ze5acZQ6EQLDXeBWfAU1gWX4viYqD4An77XmYaJwrUIi50rmR4pLkkKPj4uussHvIMdEmxYJydyXSEjJbWjAAhzhVMroa_Ay5QE1MMkL-Tgwl8xh8f9zF5uL76c3nb3P--ubu8uG-MVENphokL2bYSoJ9GNhnZY2-5YXJiQyd6a9EIHCVTlqu2ntGcdZOUyJXou04M8pj83OfW_5-3mIueXTboPQSM26zFUL0MrOWyonyPmhRzTjjpJbkZ0qvmTO_8642u_vXOv977rzOnH_HbcUb7b-JTeAXO9wDWJV8cJp2Nw2DQuoSmaBvdf-LfAN2Il_w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2844680513</pqid></control><display><type>article</type><title>Establishment and clinical application evaluations of a deep mining strategy of plasma proteomics based on nanomaterial protein coronas</title><source>ScienceDirect Freedom Collection</source><creator>Wang, Jianan ; Xie, Wei ; Sun, Longqin ; Li, Jingli ; Wu, Songfeng ; Li, Ruibing ; Zhao, Yan</creator><creatorcontrib>Wang, Jianan ; Xie, Wei ; Sun, Longqin ; Li, Jingli ; Wu, Songfeng ; Li, Ruibing ; Zhao, Yan</creatorcontrib><description>Research on plasma proteomics has received extensive attention, because human plasma is an important sample for disease biomarker research due to its easy clinical accessibility and richness in biological information. Plasma samples contain a large number of leaked proteins from different tissues in the body, immune proteins and communication signal proteins. However, MS signal suppression from high-abundance proteins results in a large number of proteins that are present in low abundance in plasma not being detected by the LC-MS method. This situation makes it more difficult to study neurological diseases, where tissue sampling is difficult and body fluid samples such as plasma or cerebrospinal fluid are both affected by signal suppression. A large number of methods have been developed to deeply mine plasma proteomics information; however, their application limitations remain to some extent. Traditional immuno- or affinity-based depletion, fractionation and subproteome enrichment methods cannot meet the challenges of large clinical cohort applications due to limited time efficiency.
In this study, a deep mining strategy of plasma proteomics was established by combing the protein corona formed by deep mining beads (DMB beads, hereafter referred to as magnetic covalent organic frameworks Fe3O4@TpPa-1), DIA-MS detection and the DIA-NN library searching method. By optimizing the enrichment step, mass spectrometry acquisition and data processing, the evaluation results of the deep mining strategy showed the following: depth, the strategy identified and quantified results of 2000+ proteins per plasma sample; stability, more than 87% of the enriched low-abundance proteins had CV < 20%; accuracy, good agreement between measured and theoretical values (1.81/2, 8.68/10, 38.36/50) for the gradient addition of E. coli proteins to a plasma sample; time efficiency, the processing time was reduced from >12h in the traditional method to <5h (incubation 30 min, washing 15 min, reductive/alkylation/digestion/desalting 4 h), and more importantly, 96 samples can be processed simultaneously in combination with the magnetic module of the automated device. The optimal strategy enables greater enrichment of neurological disease-related proteins, including SNCA and BDNF. Finally, the deep mining strategy was applied in a pilot study of multiple system atrophy (MSA) for biomarker discovery. The results showed that a total of 215 proteins were upregulated and 184 proteins were downregulated (p < 0.05) in the MSA group compared with the healthy control group. Eighteen proteins of these differentially expressed proteins were reported to be associated with neurological diseases or expressed specifically in brain tissue, 8 and 4 of which have reference concentrations of μg/L and ng/L, respectively. The alterations of ENPP2 and SLC2A1/Glut1 were reanalyzed by ELISA, further supporting the results of mass spectrometry. In conclusion, the results of the evaluation and application of the deep mining strategy showed promise for clinical research applications.
[Display omitted]
•A deep mining strategy of plasma proteomics was established by combining magnetic covalent organic frameworks (Fe3O4@TpPa-1) with data-independent acquisition (DIA) detection and DIA-NN library search.•The strategy demonstrated good profiling depth, reproducibility, reliability and processing time-efficiency.•The strategy was applied to a pilot study of multiple system atrophy for the discovery of markers.</description><identifier>ISSN: 0003-2670</identifier><identifier>EISSN: 1873-4324</identifier><identifier>DOI: 10.1016/j.aca.2023.341569</identifier><identifier>PMID: 37524462</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Biomarkers ; Deep mining beads ; Escherichia coli ; Humans ; LC-MS ; Multiple system atrophy ; Nanostructures ; Pilot Projects ; Plasma proteomics ; Protein Corona ; Proteome - analysis ; Proteomics - methods</subject><ispartof>Analytica chimica acta, 2023-09, Vol.1275, p.341569-341569, Article 341569</ispartof><rights>2023 Elsevier B.V.</rights><rights>Copyright © 2023 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c348t-8f123553aa7fb0fc37e7d1c03f08627ddec2eb304d145454bc96f33e142766283</cites><orcidid>0000-0002-1289-5660 ; 0000-0001-9338-0943</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37524462$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Jianan</creatorcontrib><creatorcontrib>Xie, Wei</creatorcontrib><creatorcontrib>Sun, Longqin</creatorcontrib><creatorcontrib>Li, Jingli</creatorcontrib><creatorcontrib>Wu, Songfeng</creatorcontrib><creatorcontrib>Li, Ruibing</creatorcontrib><creatorcontrib>Zhao, Yan</creatorcontrib><title>Establishment and clinical application evaluations of a deep mining strategy of plasma proteomics based on nanomaterial protein coronas</title><title>Analytica chimica acta</title><addtitle>Anal Chim Acta</addtitle><description>Research on plasma proteomics has received extensive attention, because human plasma is an important sample for disease biomarker research due to its easy clinical accessibility and richness in biological information. Plasma samples contain a large number of leaked proteins from different tissues in the body, immune proteins and communication signal proteins. However, MS signal suppression from high-abundance proteins results in a large number of proteins that are present in low abundance in plasma not being detected by the LC-MS method. This situation makes it more difficult to study neurological diseases, where tissue sampling is difficult and body fluid samples such as plasma or cerebrospinal fluid are both affected by signal suppression. A large number of methods have been developed to deeply mine plasma proteomics information; however, their application limitations remain to some extent. Traditional immuno- or affinity-based depletion, fractionation and subproteome enrichment methods cannot meet the challenges of large clinical cohort applications due to limited time efficiency.
In this study, a deep mining strategy of plasma proteomics was established by combing the protein corona formed by deep mining beads (DMB beads, hereafter referred to as magnetic covalent organic frameworks Fe3O4@TpPa-1), DIA-MS detection and the DIA-NN library searching method. By optimizing the enrichment step, mass spectrometry acquisition and data processing, the evaluation results of the deep mining strategy showed the following: depth, the strategy identified and quantified results of 2000+ proteins per plasma sample; stability, more than 87% of the enriched low-abundance proteins had CV < 20%; accuracy, good agreement between measured and theoretical values (1.81/2, 8.68/10, 38.36/50) for the gradient addition of E. coli proteins to a plasma sample; time efficiency, the processing time was reduced from >12h in the traditional method to <5h (incubation 30 min, washing 15 min, reductive/alkylation/digestion/desalting 4 h), and more importantly, 96 samples can be processed simultaneously in combination with the magnetic module of the automated device. The optimal strategy enables greater enrichment of neurological disease-related proteins, including SNCA and BDNF. Finally, the deep mining strategy was applied in a pilot study of multiple system atrophy (MSA) for biomarker discovery. The results showed that a total of 215 proteins were upregulated and 184 proteins were downregulated (p < 0.05) in the MSA group compared with the healthy control group. Eighteen proteins of these differentially expressed proteins were reported to be associated with neurological diseases or expressed specifically in brain tissue, 8 and 4 of which have reference concentrations of μg/L and ng/L, respectively. The alterations of ENPP2 and SLC2A1/Glut1 were reanalyzed by ELISA, further supporting the results of mass spectrometry. In conclusion, the results of the evaluation and application of the deep mining strategy showed promise for clinical research applications.
[Display omitted]
•A deep mining strategy of plasma proteomics was established by combining magnetic covalent organic frameworks (Fe3O4@TpPa-1) with data-independent acquisition (DIA) detection and DIA-NN library search.•The strategy demonstrated good profiling depth, reproducibility, reliability and processing time-efficiency.•The strategy was applied to a pilot study of multiple system atrophy for the discovery of markers.</description><subject>Biomarkers</subject><subject>Deep mining beads</subject><subject>Escherichia coli</subject><subject>Humans</subject><subject>LC-MS</subject><subject>Multiple system atrophy</subject><subject>Nanostructures</subject><subject>Pilot Projects</subject><subject>Plasma proteomics</subject><subject>Protein Corona</subject><subject>Proteome - analysis</subject><subject>Proteomics - methods</subject><issn>0003-2670</issn><issn>1873-4324</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOHDEQRa0oKAwkH8AGeZlNT_zqB2KFEC8JKZuwtqrtavDIbTe2B4kvyG_jYSDLyAuXVaeuVYeQE87WnPHu12YNBtaCCbmWirfd2Rey4kMvGyWF-kpWjDHZiK5nh-Qo5019Cs7UN3Io-1Yo1YkV-XuVC4ze5acZQ6EQLDXeBWfAU1gWX4viYqD4An77XmYaJwrUIi50rmR4pLkkKPj4uussHvIMdEmxYJydyXSEjJbWjAAhzhVMroa_Ay5QE1MMkL-Tgwl8xh8f9zF5uL76c3nb3P--ubu8uG-MVENphokL2bYSoJ9GNhnZY2-5YXJiQyd6a9EIHCVTlqu2ntGcdZOUyJXou04M8pj83OfW_5-3mIueXTboPQSM26zFUL0MrOWyonyPmhRzTjjpJbkZ0qvmTO_8642u_vXOv977rzOnH_HbcUb7b-JTeAXO9wDWJV8cJp2Nw2DQuoSmaBvdf-LfAN2Il_w</recordid><startdate>20230922</startdate><enddate>20230922</enddate><creator>Wang, Jianan</creator><creator>Xie, Wei</creator><creator>Sun, Longqin</creator><creator>Li, Jingli</creator><creator>Wu, Songfeng</creator><creator>Li, Ruibing</creator><creator>Zhao, Yan</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1289-5660</orcidid><orcidid>https://orcid.org/0000-0001-9338-0943</orcidid></search><sort><creationdate>20230922</creationdate><title>Establishment and clinical application evaluations of a deep mining strategy of plasma proteomics based on nanomaterial protein coronas</title><author>Wang, Jianan ; Xie, Wei ; Sun, Longqin ; Li, Jingli ; Wu, Songfeng ; Li, Ruibing ; Zhao, Yan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-8f123553aa7fb0fc37e7d1c03f08627ddec2eb304d145454bc96f33e142766283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biomarkers</topic><topic>Deep mining beads</topic><topic>Escherichia coli</topic><topic>Humans</topic><topic>LC-MS</topic><topic>Multiple system atrophy</topic><topic>Nanostructures</topic><topic>Pilot Projects</topic><topic>Plasma proteomics</topic><topic>Protein Corona</topic><topic>Proteome - analysis</topic><topic>Proteomics - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Jianan</creatorcontrib><creatorcontrib>Xie, Wei</creatorcontrib><creatorcontrib>Sun, Longqin</creatorcontrib><creatorcontrib>Li, Jingli</creatorcontrib><creatorcontrib>Wu, Songfeng</creatorcontrib><creatorcontrib>Li, Ruibing</creatorcontrib><creatorcontrib>Zhao, Yan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Analytica chimica acta</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Jianan</au><au>Xie, Wei</au><au>Sun, Longqin</au><au>Li, Jingli</au><au>Wu, Songfeng</au><au>Li, Ruibing</au><au>Zhao, Yan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Establishment and clinical application evaluations of a deep mining strategy of plasma proteomics based on nanomaterial protein coronas</atitle><jtitle>Analytica chimica acta</jtitle><addtitle>Anal Chim Acta</addtitle><date>2023-09-22</date><risdate>2023</risdate><volume>1275</volume><spage>341569</spage><epage>341569</epage><pages>341569-341569</pages><artnum>341569</artnum><issn>0003-2670</issn><eissn>1873-4324</eissn><abstract>Research on plasma proteomics has received extensive attention, because human plasma is an important sample for disease biomarker research due to its easy clinical accessibility and richness in biological information. Plasma samples contain a large number of leaked proteins from different tissues in the body, immune proteins and communication signal proteins. However, MS signal suppression from high-abundance proteins results in a large number of proteins that are present in low abundance in plasma not being detected by the LC-MS method. This situation makes it more difficult to study neurological diseases, where tissue sampling is difficult and body fluid samples such as plasma or cerebrospinal fluid are both affected by signal suppression. A large number of methods have been developed to deeply mine plasma proteomics information; however, their application limitations remain to some extent. Traditional immuno- or affinity-based depletion, fractionation and subproteome enrichment methods cannot meet the challenges of large clinical cohort applications due to limited time efficiency.
In this study, a deep mining strategy of plasma proteomics was established by combing the protein corona formed by deep mining beads (DMB beads, hereafter referred to as magnetic covalent organic frameworks Fe3O4@TpPa-1), DIA-MS detection and the DIA-NN library searching method. By optimizing the enrichment step, mass spectrometry acquisition and data processing, the evaluation results of the deep mining strategy showed the following: depth, the strategy identified and quantified results of 2000+ proteins per plasma sample; stability, more than 87% of the enriched low-abundance proteins had CV < 20%; accuracy, good agreement between measured and theoretical values (1.81/2, 8.68/10, 38.36/50) for the gradient addition of E. coli proteins to a plasma sample; time efficiency, the processing time was reduced from >12h in the traditional method to <5h (incubation 30 min, washing 15 min, reductive/alkylation/digestion/desalting 4 h), and more importantly, 96 samples can be processed simultaneously in combination with the magnetic module of the automated device. The optimal strategy enables greater enrichment of neurological disease-related proteins, including SNCA and BDNF. Finally, the deep mining strategy was applied in a pilot study of multiple system atrophy (MSA) for biomarker discovery. The results showed that a total of 215 proteins were upregulated and 184 proteins were downregulated (p < 0.05) in the MSA group compared with the healthy control group. Eighteen proteins of these differentially expressed proteins were reported to be associated with neurological diseases or expressed specifically in brain tissue, 8 and 4 of which have reference concentrations of μg/L and ng/L, respectively. The alterations of ENPP2 and SLC2A1/Glut1 were reanalyzed by ELISA, further supporting the results of mass spectrometry. In conclusion, the results of the evaluation and application of the deep mining strategy showed promise for clinical research applications.
[Display omitted]
•A deep mining strategy of plasma proteomics was established by combining magnetic covalent organic frameworks (Fe3O4@TpPa-1) with data-independent acquisition (DIA) detection and DIA-NN library search.•The strategy demonstrated good profiling depth, reproducibility, reliability and processing time-efficiency.•The strategy was applied to a pilot study of multiple system atrophy for the discovery of markers.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>37524462</pmid><doi>10.1016/j.aca.2023.341569</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-1289-5660</orcidid><orcidid>https://orcid.org/0000-0001-9338-0943</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-2670 |
ispartof | Analytica chimica acta, 2023-09, Vol.1275, p.341569-341569, Article 341569 |
issn | 0003-2670 1873-4324 |
language | eng |
recordid | cdi_proquest_miscellaneous_2844680513 |
source | ScienceDirect Freedom Collection |
subjects | Biomarkers Deep mining beads Escherichia coli Humans LC-MS Multiple system atrophy Nanostructures Pilot Projects Plasma proteomics Protein Corona Proteome - analysis Proteomics - methods |
title | Establishment and clinical application evaluations of a deep mining strategy of plasma proteomics based on nanomaterial protein coronas |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T15%3A07%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Establishment%20and%20clinical%20application%20evaluations%20of%20a%20deep%20mining%20strategy%20of%20plasma%20proteomics%20based%20on%20nanomaterial%20protein%20coronas&rft.jtitle=Analytica%20chimica%20acta&rft.au=Wang,%20Jianan&rft.date=2023-09-22&rft.volume=1275&rft.spage=341569&rft.epage=341569&rft.pages=341569-341569&rft.artnum=341569&rft.issn=0003-2670&rft.eissn=1873-4324&rft_id=info:doi/10.1016/j.aca.2023.341569&rft_dat=%3Cproquest_cross%3E2844680513%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c348t-8f123553aa7fb0fc37e7d1c03f08627ddec2eb304d145454bc96f33e142766283%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2844680513&rft_id=info:pmid/37524462&rfr_iscdi=true |